These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1401940)

  • 1. Selective generation of antigen-specific human hybridomas optimized for large scale growth in serum-free medium.
    Lang AB; Schürch U; Zimmermann F; Bruderer U
    J Immunol Methods; 1992 Sep; 154(1):21-6. PubMed ID: 1401940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of IgG-producing hybridomas by in vitro stimulation of murine spleen cells.
    Takahashi M; Fuller SA; Hurrell JG
    J Immunol Methods; 1987 Feb; 96(2):247-53. PubMed ID: 3492563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of somatic cell hybridization and human serum on the generation and stability of human hybridomas.
    Lang AB; Bruderer U
    Hybridoma; 1992 Feb; 11(1):99-106. PubMed ID: 1737644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of anti-tumor human monoclonal antibodies using different approaches.
    Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
    Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Monoclonal antibodies produced by human-human hybridomas].
    Chida J
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):157-64. PubMed ID: 6607711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of growth and secretion of human monoclonal antibodies by hybridomas cultured in serum-free media.
    Lang AB; Schuerch U; Cryz SJ
    Hybridoma; 1991 Jun; 10(3):401-9. PubMed ID: 1916851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of monoclonal antibodies in culture.
    Reuveny S; Velez D; Riske F; MacMillan JD; Miller L
    Dev Biol Stand; 1985; 60():185-97. PubMed ID: 3930316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of in vitro immunisation, as an adjunct to monoclonal antibody production, may result in the production of hybridomas secreting polyreactive antibodies.
    McMahon MJ; O'Kennedy R
    J Immunol Methods; 2001 Dec; 258(1-2):27-36. PubMed ID: 11684120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human anti-tetanus toxoid monoclonal antibody secreted by EBV-transformed human B cells fused with murine myeloma.
    Kozbor D; Roder JC; Chang TH; Steplewski Z; Koprowski H
    Hybridoma; 1982; 1(3):323-8. PubMed ID: 6092264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of the optimal human cell lines for development of human hybridomas.
    Abrams PG; Knost JA; Clarke G; Wilburn S; Oldham RK; Foon KA
    J Immunol; 1983 Sep; 131(3):1201-4. PubMed ID: 6350451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of specific immunoglobulin secretion by EBV-transformed lymphoblastoid cells and human-murine heterohybridomas.
    Glasky MS; Reading CL
    Hybridoma; 1989 Aug; 8(4):377-89. PubMed ID: 2550358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hybridoma growth and monoclonal antibody production in iron-rich protein-free medium: effect of nutrient concentration.
    Franĕk F; Dolníková J
    Cytotechnology; 1991 Sep; 7(1):33-8. PubMed ID: 1367699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histocompatible miniature pig (d/d haplotype): generation of hybridomas secreting A or M monoclonal antibody.
    Kaeffer B; Bottreau E; Marcon D; Olivier M; Lantier I; Salmon H
    Hybridoma; 1991 Dec; 10(6):731-44. PubMed ID: 1667778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A human hybrid hybridoma.
    Tiebout RF; van Boxtel-Oosterhof F; Stricker EA; Zeijlemaker WP
    J Immunol; 1987 Nov; 139(10):3402-5. PubMed ID: 3119707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth of human-human hybridomas in serum-free media enhances antibody secretion.
    Glassy MC; Peters RE; Mikhalev A
    In Vitro Cell Dev Biol; 1987 Nov; 23(11):745-9. PubMed ID: 3680101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of culture conditions for feline x murine heterohybridomas.
    Leidinger E; Kramberger-Kaplan E; Gemeiner M
    Comp Immunol Microbiol Infect Dis; 1993 Oct; 16(4):289-98. PubMed ID: 8281742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficient production of stable, human monoclonal antibody-secreting hybridomas from EBV-transformed lymphocytes using the mouse myeloma X63-Ag8.653 as a fusion partner.
    Thompson KM; Hough DW; Maddison PJ; Melamed MD; Hughes-Jones N
    J Immunol Methods; 1986 Nov; 94(1-2):7-12. PubMed ID: 3023493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of human-human hybridomas secreting antibody to sheep erythrocytes after in vitro immunization.
    Strike LE; Devens BH; Lundak RL
    J Immunol; 1984 Apr; 132(4):1798-803. PubMed ID: 6699402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of human IgG, IgA, and IgM anti-melanoma monoclonal antibodies utilizing lymphocytes of an actively immunized melanoma patient.
    Abdel-wahab ZA; Gillanders WE; Darrow TL; Seigler HF
    Hum Antibodies Hybridomas; 1992 Jan; 3(1):32-9. PubMed ID: 1576321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell biology of human IgM-producing hybridomas derived from a fusion of human spleen lymphocytes with mouse myeloma cells.
    Jahn S; Grunow R; Kiessig ST; Bogacheva GT; Arsenjeva EL; Hlinak A; Rocklin OV; von Baehr R
    Hybridoma; 1987 Dec; 6(6):679-87. PubMed ID: 3436627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.